about
Metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial.Changes in plasma levels of N-arachidonoyl ethanolamine and N-palmitoylethanolamine following bariatric surgery in morbidly obese females with impaired glucose homeostasis.Stimulated urine C-peptide creatinine ratio vs serum C-peptide level for monitoring of β-cell function in the first year after diagnosis of Type 1 diabetes.Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.Diabetic Retinopathy in Newly Diagnosed Subjects With Type 2 Diabetes Mellitus: Contribution of β-Cell Function.Similar magnitude of post-exercise hyperglycemia despite manipulating resistance exercise intensity in type 1 diabetes individuals.Postmarket Approval Surveillance of a Low Acquisition Cost Blood Glucose Monitoring System: Assessment of the Accuracy Following ISO 15197:2013.Daytime variability of postprandial glucose tolerance and pancreatic B-cell function using 12-h profiles in persons with Type 2 diabetes.Impending hyperglycemia in normoglycemic renal transplant recipients--an experimental predictive surrogate.Comparison of rival metabolic syndrome classifications against pathophysiological markers in renal transplant recipients.Relative and absolute contributions of postprandial and fasting plasma glucose to daytime hyperglycaemia and HbA(1c) in subjects with Type 2 diabetes.Acute effects of valsartan on insulin sensitivity in obese, non-hypertensive subjects with and without type 2 diabetes.Reductions in resistance exercise-induced hyperglycaemic episodes are associated with circulating interleukin-6 in type 1 diabetes.Estimates of the relative and absolute diurnal contributions of fasting and post-prandial plasma glucose over a range of hyperglycaemia in type 2 diabetes.Impact of single and multiple sets of resistance exercise in type 1 diabetes.The effect of rosuvastatin on insulin sensitivity and pancreatic beta-cell function in nondiabetic renal transplant recipients.Use of cystatin C-based estimations of glomerular filtration rate in patients with type 2 diabetes.Beta-cell response during a meal test: a comparative study of incremental doses of repaglinide in type 2 diabetic patients.A comparison of preprandial insulin glulisine versus insulin lispro in people with Type 2 diabetes over a 12-h period.The systemic inflammatory response to exercise in adults with cystic fibrosis.Influence of body weight on the performance of glomerular filtration rate estimators in subjects with type 2 diabetes.Stability of proinsulin in whole blood.Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.Association between the preoperative fasting and postprandial C-peptide AUC with resolution of type 2 diabetes 6 months following bariatric surgery.A comparison of the pharmacodynamic profiles of insulin detemir and insulin glargine: a single dose clamp study in people with type 2 diabetes.Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus.Insulin resistance and inflammation - A further systemic complication of COPD.Relationship between HbA1c and indices of glucose tolerance derived from a standardized meal test in newly diagnosed treatment naive subjects with Type 2 diabetes.Accuracy Evaluation of a Blood Glucose Monitoring System According to EN ISO 15197:2015.Comparison of IFCC-calibrated HbA(1c) from laboratory and point of care testing systems.Comparison of a point-of-care analyser for the determination of HbA1c with HPLC method.Proinsulin in the identification and risk stratification of gestational diabetes mellitus: study protocol for a prospective, longitudinal cohort study40th EASD Annual Meeting of the European Association for the Study of DiabetesBridging-type enzyme-linked immunoassay for zinc transporter 8 autoantibody measurements in adult patients with diabetes mellitusComparison of the pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetesExperience of the introduction of routine antibody testing in primary care and of running a trial for latent autoimmune diabetes in adults (LADA)Loss of CXCR3 expression on memory B cells in individuals with long-standing type 1 diabetesMicrosampling Collection Methods for Measurement of C-peptide in Whole BloodPerformance evaluation of a self-administered home oral glucose tolerance test kit in a controlled clinical research settingThe impact of structured self-monitoring of blood glucose on glycaemic variability in non-insulin treated type 2 diabetes: The SMBG study, a 12-month randomised controlled trial
P50
Q33654881-C2F1EC81-B1D2-412D-A720-3C08CAD1BA9AQ33654881-D1852DEF-52FF-42A8-BD55-54CF2082AA23Q35271208-49DD8DD9-860A-4206-AD04-71112BB782CAQ39593898-9A081103-1D54-427B-8D41-ADF5D358DD5DQ40088521-7183B2CD-F771-4F5B-8BC4-F6F475F9E3F0Q40336678-A5129464-B4B4-41FA-9D3E-153699A47F12Q41005285-32A2E853-9CF9-4C1A-8A93-3669AA37B2EBQ42392236-40159721-5DAA-4AB5-B198-4FBC38F2025EQ43034923-FF602342-F3BD-42A0-B3F0-61EF118F75CDQ43114304-F6CBC881-1F17-4D6A-90E3-E1A265082E03Q43166682-829FEDA2-C577-439F-9E21-1A92E7B07F80Q43245616-A1A95B85-A3AD-421E-B084-C292C86A3B64Q44027258-CC277344-95AF-43DA-82CC-818BD69309A9Q44518860-3D13E20C-9715-47A3-902F-69E21C80F785Q44777930-3862AC99-B43C-470B-89DE-5F058FD701CFQ45892468-523B5B56-917E-44AA-971C-AF22FD8243AAQ46002315-7D140E76-A39C-4106-8297-CAA07FFFF77CQ46017056-93E38315-FA31-400F-B36F-0D67E3AAC6BEQ46458841-D4DC51B0-1A72-4B43-ABF0-B2D14AF0004CQ46829580-87CBE3FF-F5CE-44F6-8497-30D63B5219E6Q46887463-FFA2CB4A-C7D3-4ECD-9687-7C68D3ADC334Q46952994-CCB4E0CD-169E-4B11-A2C3-3AE5DA08844AQ47757589-4B17DC1A-BB1B-477D-B8C2-5CD765255379Q50656243-4D1C8F17-F6D9-471E-9348-446DAE381A19Q51296793-4620DBCA-D65A-476A-95B4-4CA2D67D21A4Q51332542-1D0314EE-1804-46CB-9066-48FC05B14C65Q51369597-64F2EA9F-B226-4CA0-995B-65EE7EB77E07Q51470730-3B775CDD-AE93-47BB-8C72-0F1B4BB858FBQ51491716-0E7A3DA2-5C4E-4CD9-B2BA-9F4D68937B85Q53102223-ADBC090D-BB3C-492C-BF92-915954E2E818Q53148366-1B099741-B559-4775-A69D-0251294C347BQ55057449-D351BEB3-C36C-44F5-A5CE-B937C2D2EE9AQ56515793-24B828D9-C594-4376-82A1-BAE4C0558B7CQ57249806-20FBB59F-D42C-4892-A9F2-D39F19C7F4C4Q57951341-B4B0F54F-98FB-4D0F-8589-9E7B60993EBAQ57951508-AC5BA774-505A-46DF-8655-E8EF8486F808Q61713079-AC94C002-AD1D-453E-A69D-E2664A68827EQ62672849-B27A452B-7577-418B-BD99-CAE1D2B4B7C8Q88009494-C0BFD449-F34E-400D-9880-1E5CE12F87A8Q93018355-A5785927-CA7B-4C84-938C-1E7FD5888E3D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gareth J Dunseath
@ast
Gareth J Dunseath
@en
Gareth J Dunseath
@es
Gareth J Dunseath
@nl
type
label
Gareth J Dunseath
@ast
Gareth J Dunseath
@en
Gareth J Dunseath
@es
Gareth J Dunseath
@nl
prefLabel
Gareth J Dunseath
@ast
Gareth J Dunseath
@en
Gareth J Dunseath
@es
Gareth J Dunseath
@nl
P106
P21
P31
P496
0000-0001-6022-862X